E-LIB Suche - Ergebnisse für: Quek, RGW

1

EE280 Budget Impact (BI) of First-Line (1L) Cemiplimab Mono..:

Quek, RGW ; Theriou, C ; Smare, C...
Value in Health. 25 (2022) 7 - p. S388 , 2022

Link: https://doi.org/10.1016/..

2

HTA9 Differences in Guidance on Pro Evidentiary Requirement..:

Chassany, O ; van Engen, A ; Lai, L...
Value in Health. 25 (2022) 7 - p. S505 , 2022

Link: https://doi.org/10.1016/..

3

Real-World Outcomes and Prognostic Factors Among Patients w..:

Ge W ; Wu N ; Jalbert JJ...
https://www.dovepress.com/real-world-outcomes-and-prognostic-factors-among-patients-with-advance-peer-reviewed-fulltext-article-CMAR. , 2022

Link: https://doaj.org/article..

4

A systematic review of the international prevalence of BRCA..:

Armstrong N ; Ryder S ; Forbes C..
https://www.dovepress.com/a-systematic-review-of-the-international-prevalence-of-brca-mutation-i-peer-reviewed-article-CLEP. , 2019

Link: https://doaj.org/article..

5

A systematic review of international guidelines and recomme..:

Forbes C ; Fayter D ; de Kock S.
https://www.dovepress.com/a-systematic-review-of-international-guidelines-and-recommendations-fo-peer-reviewed-article-CMAR. , 2019

Link: https://doaj.org/article..